Search

everythinglearnresearchcommunity

for

Search:↓

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

New treatments for PCOS focus on managing symptoms and improving fertility.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Platelet-rich plasma may improve embryo genetics in IVF.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The combined therapy improved symptoms in PCOS patients.

Melatonin may help treat PCOS symptoms in rats.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Minoxidil boosts hair growth by triggering growth factor release from specific stem cells.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.